Navigation Links
Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
Date:11/22/2011

NEW YORK, Nov. 22, 2011 /PRNewswire/ -- Rentricity, one of the original start-up companies in the New York Accelerator for a Clean and Renewable Economy (NYC ACRE) cleantech support system, has been named a Later Stage Global Top 10 greentech company – chosen from a field of 4,000. The award by the Global Cleantech Cluster Association (GCCA) also named Rentricity as the winner of the "Best of Water" category for 2011.

(Logo: http://photos.prnewswire.com/prnh/20091027/NY99197LOGO)

Rentricity recovers energy from excess water pressure in pipes to produce clean, renewable electricity. It targets water, wastewater and industrial infrastructure to produce electricity that can be sold into the electric grid or used behind-the-meter.

As one of the Global Top 10, GCCA recognized Rentricity for winning access to sources of growth capital and management guidance. GCCA also cited Rentricity for significant success in growing the cleantech industry in New York City and for its support of green job growth in the region.

"Our Top 10 winners are truly the best in class and companies to watch," said Ben Taube, chairman of the GCCA. "In each category, these companies are making both broad strides in their global industries as well as working closely with their regional cleantech clusters to build sustainable green economies and jobs. We are thrilled to name Rentricity among the GCCA Global Top 10 for 2011."

Rentricity became a commercial venture in 2008 and joined NYC ACRE the following year. Founder and President Frank Zammataro kept the young company self-funding, and last year it generated $500,000 in revenue.  Rentricity has completed two commercial projects and has four other projects in development. Among them is a project fun
'/>"/>

SOURCE Polytechnic Institute of New York University
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
2. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
3. Global Apoptosis Industry
4. Global Biochip Markets: Microarrays and Lab-on-a-Chip
5. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
6. Spinal Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
7. Informex Introduces a Thorough Global Pharma Perspectives Conference
8. Global Automated And Rapid Microbiological Tests Industry
9. BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo
10. United States Holds Global Lead in Breast Cancer Research Publications as China Surges to Forefront, According to Report
11. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... , March 27, 2015  CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... and 12 months ended December 31, 2014.  ... million), or ($0.05) per share, for the three months ...
(Date:3/26/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... certain matters, including the appointment of auditors, its annual ... 2015 (the "Meeting") was adjourned, as previously disclosed on ... a.m. ( Toronto time). The date ... previous disclosed. The Meeting will reconvene at the offices ...
(Date:3/26/2015)... 2015 Neogen Corporation (NASDAQ: NEOG ) ... quarter of fiscal 2015, which ended Feb. 28, increased ... $6,575,000. Earnings per share in the current quarter were ... net income increased 17% over prior year to $24,142,000, ... per share, for the same period a year ago. ...
Breaking Biology Technology:SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6SQI Diagnostics Inc. Announces Adjournment of Meeting 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... being used by the Food and Drug Administration to assess ... the full effects of the fish,s widespread production, according to ... Science . The salmon, whose genome contains inserted genes ... modified animal approved for human consumption in the United States. ...
... Medizone International, Inc. (OTC Bulletin Board: MZEI ... a common stock purchase agreement establishing a $10,000,000 equity line ... for a two-year term.  Under the terms of the agreement, ... discount to the average closing bid price over a five ...
... ... ... var shortURL = ""; BitlyCB.alertResponse ... grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in ...
Cached Biology Technology:FDA review on transgenic salmon too narrow 2FDA review on transgenic salmon too narrow 3Medizone International Secures $10,000,000 Funding Commitment 2Medizone International Secures $10,000,000 Funding Commitment 3YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 2YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 3YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 4YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 5YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 6YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 7YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 8YM BioSciences Expands Phase I/II Trial for JAK Inhibitor CYT387 9
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
(Date:3/10/2015)... YORK , March 10, 2015  Continuing its ... the Unexpected, Hammacher Schlemmer introduces The Eye Scanning ... identity before granting access to secure websites or sensitive ... to verify travelers at international borders, the device has ... distinctive pattern points of the iris, converting them into ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... of drugs used to treat parasitic infections such as malaria ... a new WSU-led study has found., Researchers discovered that simple ... its ability to affect specific human proteins involved in the ... how relatively simple the molecules are that we modified and ...
... is available in German . ... In the wild Arabidopsis thaliana uses the same ... its size in half as found in semi-dwarf varieties of rice and ... various plant species apparently fall back on the same genes in their ...
... Northwestern University Feinberg School of Medicine in Chicago, a ... led by Kezhong Zhang, Ph.D., has contributed to an ... inhibitor for the treatment of rheumatoid arthritis. The ... microbiology and Wayne State,s Center for Molecular Medicine and ...
Cached Biology News:Researcher finds potential new use for old drugs 2The secret of short stems 2The secret of short stems 3Wayne State researchers discover specific inhibitor for rheumatoid arthritis treatment 2
Collected from animals that are 16 to 18 months old. Sterile, Cell culture tested, ID clarifier: USA Origin...
Contact us for more information...
Contact us for more information...
... designed to rapidly and reliably amplify ... patented APA Technology. APAgene provides hassle-free, ... competitive price. All necessary ingredients are ... Kit can be used for identifying ...
Biology Products: